Immunovant (IMVT) shares outstanding
Immunovant (IMVT) had 182.42M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 20.4% higher than the 151.57M of fiscal 2025. Figures as of 18 Nov 2026, 10:47 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2026
- 182.42M
- Change on fiscal 2025
- +20.4%
- Growth, 5 years
- +15.8% a year
- Highest on record
- 182.42Mfiscal 2026
- Lowest on record
- 87.76Mfiscal 2021
- Fiscal years on record
- 62021–2026
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Immunovant shares outstanding, in more detail
The market data feed counts 206.95M shares outstanding today.
Over the five fiscal years to 2026 the diluted share count grew at a compound 15.8% a year. Across the 6 fiscal years on record (2021–2026), the highest was 182.42M in fiscal 2026 and the lowest 87.76M in fiscal 2021.
Shares outstanding by fiscal year
Immunovant shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2026 | 182.42M | 20.4% up | |
| 2025 | 151.57M | 9.8% up | |
| 2024 | 138.10M | 12.2% up | |
| 2023 | 123.08M | 12.2% up | |
| 2022 | 109.68M | 25.0% up | |
| 2021 | 87.76M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
Immunovant, figure by figure
- Immunovant market cap
- Immunovant revenue
- Immunovant earnings
- Immunovant earnings per share (EPS)
- Immunovant P/E ratio
- Immunovant P/S ratio
- Immunovant P/B ratio
- Immunovant free cash flow
- Immunovant operating margin
- Immunovant dividend
- Immunovant total debt
- Immunovant cash on hand
- Immunovant total assets
- Immunovant return on equity (ROE)
- Immunovant return on invested capital (ROIC)
Immunovant (IMVT) overview: price, valuation and scorecardAll health care companies by market value
Immunovant shares outstanding: questions and answers
How many shares does Immunovant have?
Immunovant (IMVT) had 182.42M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 20.4% higher than the 151.57M of fiscal 2025. The market data feed counts 206.95M shares outstanding today.
What is the growth rate of Immunovant's diluted share count?
Over the five fiscal years to 2026 the diluted share count grew at a compound 15.8% a year.
What are the highest and lowest diluted share count figures on record for Immunovant?
Across the 6 fiscal years on record (2021–2026), the highest was 182.42M in fiscal 2026 and the lowest 87.76M in fiscal 2021.
How is Immunovant's diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Immunovant it is on record here for 6 fiscal years, 2021 to 2026.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Immunovant (IMVT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/IMVT/shares-outstanding
Underlying data: the company's filings with the SEC and Yahoo Finance.